In 1956, Walshe used D-penicillamine (pen) to treat patients with Wilson's disease (Walshe 1956 ). Because of this discovery, suffering from this disease has been greatly alleviated. However, there are instances where patients do not respond to pen and conditions are not improved by this agent. Again, in 1969, Walshe used triethylenetetramine (trien) for the first time to treat Wilson's disease and met with success in patients who did not respond to penicillamine (Walshe 1969) . We have studied the interaction of pen and trien with copper ions, and their equilibrium reaction with copper bound to human albumin. Mobilization, organ distribution and excretion of copper by these two agents were investigated in detail in order to gain an understanding of their mode of action in the removal of excess copper in Wilson's disease.
Interaction ofCopper with Pen and Trien Copper-pen: Two types of complexes are formed when copper and pen are mixed. The complexes formed are dependent on the copper:pen molar ratio and counter ion used. One is a pink coloured complex and the other is a colourless complex. Both complexes are polymeric in nature.
The pink coloured complex with Amax at 525 nm is formed in the presence of halide ion. Chloride ion was shown to be an integral part of the complex by using 67CU, 36C1 and pen at pH 7.4. The complex was separated by thin-layer chromatography according to the method used in identifying various copper-amino acid complexes (Sarkar & Kruck 1967) . The thin-layer plate was first exposed for 67Cu and then for 36C1 after 67Cu had been allowed to decay. Both 67Cu and 36CI were detected in the same complex. The results are in accord with a similar report about the halide ion dependence of the complex (Wright & Frieden 1975) . Recently, X-ray crystallography of a purple complex formed by copper and pen showed a mixed valence cluster with composition [Cu(I)8 Cu(II)6 Pen12 Cl]5 The Cl-ion is located at the centre of the cluster (Birker & Freeman 1976 ).
Copper-trien: Trien is one of the classical polyamine type of chelating agents known to inorganic chemists for several decades. It is generally regarded as a tetradentate ligand which can adopt one of several conformations when bound to a metal ion; with copper, it is constrained to a near square-planar conformation when all four nitrogen atoms are bound to the central cupric ion.
However, some doubts have been expressed in the literature whether, in aqueous solution, trien is tetradentate or tridentate towards the copper ion (Bosnich et al. 1966) . The reasons for this conflict arise, we believe, because (a) impure trien has been used in many cases, and (b) there has been no attempt to characterize the species present in aqueous solution.
We finally obtained pure trien in the form of trien 4HCl via fractional distillation of commercial trien and intermediate crystallization of the trien 2H2SO4 salt. Purity was greater than 99.8 % as judged by elemental analysis, electrophoresis and potentiometric titration. Attempts to synthesize trien, as a route to obtaining "4C-labelled material, have so far been unsuccessful.
We have also completed a potentiometricspectroscopic analysis to determine the species present and their stability constants in the aqueous Cu(II)-trien system (25°C, 0.15 M NaCI) by the method outlined by Sarkar and Kruck (1973) . Over the pH range 4.0-10. used, but nothing corresponding to a molecular weight of 27000-30000. The amount of radioan equal distribution (67Cu activity) of the low molecular weight species on both sides of the membrane.
The results are shown graphically in Fig 1 . Now one could envisage that if any chelating agent is to be therapeutically useful, then one of its functions would be to mobilize copper in the bloodstream as membrane-diffusable low molecular weight species. Pen, as can be seen in Fig 1, is poor in this respect, only 30% of the Cu(II) bound to albumin being released in the form of low molecular weight species in the presence of a large excess of pen. In contrast, trien is very efficient, 86% of the Cu(II) being mobilized by an equimolar amount of the ligand.
Several explanations can be offered for the relatively poor pen performance: (1) there is some binding of the pen to the albumin (either by salt linkage or disulphide bond formation); (2) there is some unfavourable steric interaction which prevents formation of an intermediate ternary complex albumin-copper-pen; (3) the pen forms high molecular weight polymeric complexes with copper ions; and (4) the pen is undergoing prior oxidation to the disulphide form.
Equilibrium dialysis experiments involving no copper showed negligible binding between the protein and pen under the above conditions and hence ruled out (1). Explanation (2) activity in the second fraction increases as the concentration of pen is raised (curves B and C, Fig 2) and therefore suggests this to be a copperpen polymer. Further evidence for this was obtained by using L-cysteine instead of pen. L-cysteine and D-pen behave similarly towards Cu(II)-albumin in terms of low molecular weight species and polymer formation (Fig 1) . By using double labelling, i.e. 67Cu and 14C, 14C activity was assayed six weeks after measuring the 67CU activity and then remeasured until the activity reached a constant level. Assay was with a Nuclear Chicago Mark I three-channel liquid scintillation counter (calibration and corrections being made in the normal way) and we observe that the second peak contains both L-cysteine and copper (Fig 3) . Further work is required to elucidate the nature of this polymer and its dependence on chloride ion. To date, we have evidence that the same polymer is formed in aqueous solutions os copper salts with pen and that its formation if very complex (dependent on C1-, 02, time, and copper:pen ratio), it may also be heterogeneous.
Of most significance here is the fact that even at very high pen concentrations, most of the activity is still in the copper-albumin fraction, e.g. at copper-albumin:pen ratios of 1:4 and 1:10, the amount of copper-albumin complex remaining is 74 % and 55 % respectively. Presumably, the polymer formation prevents any further removal of copper from the protein. Although these studies are of chemical interest, they do not reflect the clinical conditions where, for example, the albumin:copper ratio is very much higher in favour of albumin. The penicillamine concentration found in blood serum is also very much lower than that used in the above experiments.
We therefore set up the dialysis experiment to reflect more closely the clinical conditions. Thus, on one side of the membrane clinical concentrations of albumin and copper were added together with the appropriate amount of D-pen, this was then dialysed against a buffered saline solution. The amounts of pen used are based on levels of 0.02-0.100 ,umol/ml human plasma observed 1-3 h after a 0.15-1.0 g pen dose. As can be seen from Table 1 , pen has a negligible effect in terms of copper mobilization even when the albumin to copper ratio is very much reduced to the levels typical of those observed in the plasma of Wilson's disease patients (i.e. 29.60 :.60, alb:Cu(II) shown in lower half of Table 1 ). Trien, on the other hand, is very effective even at the high albumin:copper ratios. These results are consistent with those observed with whole human blood serum presented in the next section.
Effect cfPen and Trien on the Mobilization ofCopper in Human Blood Serum
Ultracentrifugation experiments were carried out to determine the mobilization of copper by trien and pen when added to serum. Pooled normal human serum of known albumin concentration was used. Cupric chloride labelled with trace amounts of 67CU was dissolved in physiological saline and added to the serum to give a copper: albumin molar ratio of 0.25. The pH of this was adjusted to 7.4.
The trien or pen was prepared in a concentrated form in physiological saline; the pH was adjusted to 7.4 and small volumes of these solutions were added to aliquots of the labelled activity as previously described. This was compared to a similar sample taken before centrifugation. The activity in the supernatant is expressed as the percentage of the activity in the sample before centrifugation ( Table 2 ).
The results show that trien is capable of mobilizing copper at a low trien:albumin ratio. Pen, on.the other hand, requires a much higher pen:albumin ratio before any copper appears in the small molecular weight fraction of serum.
These results are consistent with those from the equilibrium dialysis experiments.
Organ Distribution ofCopper Following Administration ofPen and Trien
The introduction of chelating agents into the body of a rat must affect the distribution of copper. Experiments were devised to determine the distribution of 'mobilizable' copper (copper capable of equilibrating with radioactive copper within three minutes of injection) in serum, liver and kidney of rats. Trien and pen (40 mg/kg body weight) were introduced into the body and their effect on mobilizable copper in the body was monitored over a period of time.
The techniques used in these experiments were similar to those developed previously in our laboratory (Harris & Sass-Kortsak 1967) . Male Wistar rats, weighing 250-350 g, were used. The animals were starved overnight before the experiment. Ether was used as an anaesthetic for all injections and samplings.
A tracer dose of 67CU carried by 10 % rat serum and physiological saline was injected into the inferior vena cava of the experimental animal 3 min before samples were taken. All measurements for copper are based on the equilibration of the radioactive copper with the copper available in the animal. This copper we designate 'mobilizable', so results ignore all nondialysable copper. The results as given in Table 3 are expressed as a percentage of the total dose of 67Cu injected. Total dose was determined from the total counts in the syringe before injection, less the counts remaining in the syringe after injection. Corrections were made for the decay factor of 67CU when calculating the percentage of the dose.
The equivalent of 40 mg of trien or pen per kg body weight of the rat was injected into the tail vein. The pH of the injected solution was adjusted Table 3 Distribution of copper in rats after injection of chelating agents A40.5 (7) 1.2 ±0.2(7) 6.1 10.9 11.8 9.1 ±0.9(6) ± 1.4(6) ±2.1(6) ± 1.8 (7) Tinte after inijecting pen 15 min 30 min 60 min 120 min 24.6 ±6.4(7)
1.8 ±0.9(7)
10.4 ± 1.6(7) 5.7 +-0.8(7) 1.6 ±0.2(7) 20.0 ±2.9(6) +0.4(9)
6.9 ± 1.0(8) to 7.4. The final volume injected did not exceed 0.6 ml. All solutions of the chelating agents were prepared immediately before injection.
Blood serum: Blood was removed from the inferior vena cava close to the point of injection of the 67Cu. The withdrawal was started 3 min after the introduction of radioactive copper. The blood was allowed to clot, then spun, and an aliquot of the serum removed for 67Cu assay. The total counts in serum were calculated on the basis of 40.4 ml of serum per kg body weight of a rat. Two ml of the serum were centrifuged at a high centrifugal force to remove large protein molecules. Tests in this laboratory show that protein in the supernatant is less than 0.3 % of the total protein, and that albumin in the supernatant is less than 0.15 mg/ml. An aliquot of the supernatant was removed from the upper quarter of the centrifuge tube. A measured volume was counted for radioactivity and this was compared with the serum sample to determine the percentage of 67Cu bound to small molecules. As was expected from our previous results, the presence of trien significantly increased the amount of copper bound to small molecules, with no decrease even after 2 h (Table 3) . Penicillamine had no visible effect on the amount of low molecular weight species.
Liver: After removing the blood from the animal, the liver was taken out, placed in ice-cold 0.25 M sucrose solution, trimmed, blotted and weighed. A portion (1-2.5 g) was homogenized in 0.25 M sucrose. An aliquot was assayed for radioactivity and the rest was centrifuged at 36000 rpm for 90 min. The soluble fraction was decanted and an aliquot counted for radioactivity. Proteins were removed from the soluble fraction by centrifuging the sample.
The liver shows a significant change in the distribution of copper. The amount of copper entering the soluble fraction of the liver is decreased compared to normal, indicating that the normal pathways for uptake of copper have been affected. Trien itself appears unable to enter the liver, as the amount of copper bound in the soluble fraction is actually significantly decreased, and it is unlikely that a protein more efficient than trien would be in the soluble fraction. Pen tends to increase the amount of copper in the whole liver, but this effect is transitory, and is accompanied by a decrease in copper levels in the soluble fraction.
Kidney: Both kidneys were removed, trimmed of vessels and clots, rinsed and counted in a deepwellgamma counter. Total counts are expressed as a total of the 67Cu dose injected.
An increase in copper is seen after the injection of pen and trien. The increase with pen is slower; only after 2 h is it significant. The trien shows a marked increase in the level of copper in the kidney after 15 min, and the increase is returning to normal after 2 h. Excretion ofCopper Following Administration ofPen and Trien The measurement of the amount of copper being excreted through the kidney is a more effective indicator of the importance of these chelating agents in the removal of copper from a physiological point of view.
Male Wistar rats, 300-400 g in weight, were used for injection studies. Tail cups were in place to prevent contamination from faeces. The rats were caged in copper-free plastic cages and dextrose in deionized water was the only sustenance given during the experiment.
The agent to be tested was dissolved in saline, the pH adjusted to 7.4, and not more than 0.8 ml was injected immediately into the tail vein of the rat. The amount injected was the molar equivalent of 1, 20, 40 or 80 mg of pen per kg body weight of the rat. The urine was collected in copper-free containers kept on ice for 24 h. Urine samples were collected from the same rat under the same conditions, both before and after injection. Copper analysis was done on each urine sample. The results as given in Table 4 are expressed as ,ug of copper excreted in excess of the base line. The average base line excretion for these rats was 8.37 ±1.46 jig/day. Parallel experiments are presently being conducted with copper-loaded rats (one ml of a 1 % copper sulphate solution per kg body weight being injected per day for a five-day period). To date, the results show both pen and trien to be equally effective in removing the copper.
Conclusions
Copper-trien is a small molecular complex, whereas the copper-pen complex is polymeric in nature. Trien effectively competes for copper bound to albumin, whereas pen performs relatively poorly. Similar results were observed in the whole human serum. Pen mobilizes copper in the liver, while trien appears to be unable to enter the liver. Both agents mobilize copper in kidney and both effectively remove copper through urinary excretion. Our results are in accord with the conclusions of Walshe (1973) that these two ligands act on different pools of copper in patients with Wilson's disease. However, our results are in variance with the conclusion that trien mobilizes copper from tissue while pen binds plasma copper rendering it available for filtration at the glomerulus. The possible causes for this discrepancy may be that pure trien could not be obtained by the previous method (Dixon et al. 1972) , and that Walshe used very much higher concentrations of pen and trien in his plasma filtration studies (molar ratios of ligand :copperalbumin of several thousand, explain his observation of a 72.9 % mobilization of copper). However, the different mode of action of these two agents in mobilizing copper as originally proposed by Walshe concurs with our conclusion.
